Back
First Trust NASDAQ Technology Dividend Index Fund Vs. Cidara Therapeutics Industry Stock Comparison
Sell
44
TDIV
First Trust NASDAQ Technology Dividend Index Fund
Last Price:
$91.59
Seasonality Move:
-0.71%
Buy
70
CDTX
Cidara Therapeutics
Last Price:
$62.71
Seasonality Move:
-9.13%
Sell
44
First Trust NASDAQ Technology Dividend Index Fund (TDIV)
is a Sell
Is First Trust NASDAQ Technology Dividend Index Fund a Buy, Sell or Hold?
-
The current First Trust NASDAQ Technology Dividend Index Fund [TDIV] share price is $91.10. The Score for TDIV is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
TDIV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
70
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy, Sell or Hold?
-
The current Cidara Therapeutics [CDTX] share price is $61.85. The Score for CDTX is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TDIV Stock Price Chart
What is First Trust NASDAQ Technology Dividend Index Fund's stock price today?
-
The First Trust NASDAQ Technology Dividend Index Fund share price today is $91.10Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TDIV is experiencing buying pressure, which is a positive indicator for future bullish movement.
CDTX Stock Price Chart
What is Cidara Therapeutics's stock price today?
-
The Cidara Therapeutics share price today is $61.85Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
TDIV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 22.3 | Buy |
Relative Strength Index (14 RSI): | 58.99 | Buy |
Chaikin Money Flow: | 55251 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
CDTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 7.15 | Buy |
Relative Strength Index (14 RSI): | 70.27 | Buy |
Chaikin Money Flow: | -100733 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
TDIV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 91.79 | Sell |
20-day SMA: | 91.49 | Sell |
50-day SMA: | 87.03 | Buy |
200-day SMA: | 80.39 | Buy |
8-day EMA: | 88.84 | Buy |
20-day EMA: | 69.11 | Buy |
50-day EMA: | 39.35 | Buy |
200-day EMA: | 11.99 | Buy |
CDTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 59.56 | Buy |
20-day SMA: | 53.91 | Buy |
50-day SMA: | 37.68 | Buy |
200-day SMA: | 24 | Buy |
8-day EMA: | 59.74 | Buy |
20-day EMA: | 53.31 | Buy |
50-day EMA: | 42.08 | Buy |
200-day EMA: | 26.97 | Buy |
First Trust NASDAQ Technology Dividend Index Fund Earnings Growth & TDIV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cidara Therapeutics Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.76 per share, and a decrease next year of $0.53 per share.
First Trust NASDAQ Technology Dividend Index Fund Technical Analysis
Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cidara Therapeutics Technical Analysis
Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |